We are live on ! Find out more
WST icon

West Pharmaceutical
WST

302 hedge funds and large institutions have $6.72B invested in West Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 118 increasing their positions, 96 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,006% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $48K

23% more repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 96

6% more capital invested

Capital invested by funds: $6.36B → $6.72B (+$352M)

2.76% more ownership

Funds ownership: 91.55% → 94.31% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

10% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 41

2% less funds holding

Funds holding: 309 → 302 (-7)

Holders
302
Holders Change
-7
Holders Change %
-2.27%
% of All Funds
7.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
37
Increased
118
Reduced
96
Closed
41
Calls
$1.01M
Puts
$48K
Net Calls
+$963K
Net Calls Change
+$170K

Top Buyers

1
William Blair Investment Management
William Blair Investment Management
Illinois
+$80.4M
2
Artisan Partners
Artisan Partners
Wisconsin
+$76.2M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$48.1M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$47.1M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$33.7M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$65.5M
2
BlackRock
BlackRock
New York
-$29.8M
3
O
OppenheimerFunds
New York
-$28.7M
4
CWAM
Columbia Wanger Asset Management
Illinois
-$21.4M
5
Morgan Stanley
Morgan Stanley
New York
-$19.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
176
Stevens Capital Management
Pennsylvania
$947K +$890K +9,836 New
NMIMC
177
Northwestern Mutual Investment Management Company
Wisconsin
$932K -$270K -2,981 -24%
SIA
178
Sit Investment Associates
Minnesota
$924K +$869K +9,600 New
SAM
179
Securian Asset Management
Minnesota
$903K +$9.05K +100 +1%
CAM
180
CGOV Asset Management
Ontario, Canada
$903K +$679K +7,500 New
GC
181
Guggenheim Capital
Illinois
$892K +$54.3K +600 +7%
FCI
182
Financial Counselors Inc
Kansas
$882K -$528K -5,832 -39%
FAM
183
Fred Alger Management
New York
$866K -$362K -4,000 -31%
SAM
184
Silvercrest Asset Management
New York
$865K +$1.63K +18 +0.2%
TP
185
Truvvo Partners
New York
$852K +$78.1K +863 +11%
HSBC Holdings
186
HSBC Holdings
United Kingdom
$822K +$100K +1,106 +15%
MCIM
187
Meadow Creek Investment Management
Georgia
$792K +$104K +1,148 +16%
V
188
Veritable
Delaware
$790K +$46.7K +516 +7%
AG
189
Advisor Group
Arizona
$767K -$1.63K -18 -0.2%
Wellington Management Group
190
Wellington Management Group
Massachusetts
$728K +$684K +7,554 New
FA
191
FDx Advisors
Illinois
$684K +$21.4K +236 +3%
Millennium Management
192
Millennium Management
New York
$659K -$65.5M -723,479 -99%
CI
193
Cigna Investments
Connecticut
$633K +$155K +1,716 +35%
EP
194
Elkfork Partners
Oregon
$623K +$81.6K +902 +16%
US Bancorp
195
US Bancorp
Minnesota
$613K +$32K +354 +6%
LIA
196
LS Investment Advisors
Michigan
$576K -$18.5K -205 -3%
N
197
Natixis
France
$547K +$2.99K +33 +0.6%
WA
198
Wheatland Advisors
Pennsylvania
$539K – – –
EMG
199
Ellington Management Group
Connecticut
$539K +$507K +5,600 New
SCM
200
Shelton Capital Management
Colorado
$532K – – –
6 7
8
9 10

WST Hedge Fund Activity: Q3 2017 in Review

302 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2017, worth a combined $6.72B — up 5.5% from $6.36B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of WST and 37 opened new positions — a net loss of 4 holders — while 96 trimmed existing stakes and 118 added.

The largest buyer was William Blair Investment Management, opening a new position worth an estimated $80.4M. The largest seller was Millennium Management, cutting an estimated $65.5M.

  • 302 institutional investors held West Pharmaceutical (WST) as of Q3 2017, down from 309 in Q2 2017.
  • Funds reported $6.72B of West Pharmaceutical stock for Q3 2017, up 5.5% quarter-over-quarter.
  • 37 funds opened new West Pharmaceutical positions in Q3 2017 and 41 closed out, a net change of -4 holders.
  • The largest West Pharmaceutical buyer in Q3 2017 was William Blair Investment Management, an estimated $80.4M added.
  • The largest West Pharmaceutical seller in Q3 2017 was Millennium Management, an estimated $65.5M sold.

Based on aggregated 13F filings for Q3 2017.